Regulatory & Safety

Headlines > All Regulatory & Safety News

Email this page News by email Send a press-release

Net earnings tumble at Akzo

16-Apr-2003 - Akzo Nobel, Dutch pharmaceuticals, coatings and chemicals company, reports first quarter net earnings of €164 million, a considerable 30 per cent below the first quarter...

Celltech lays claims to OGS

14-Apr-2003 - UK biotechnology bellwether Celltech has emerged victorious in the bidding battle for Oxford GlycoSciences. OGS reluctantly gave in to Celltech's pressure on April 11, after...

Vitalife closes first fund

14-Apr-2003 - Vitalife, an Israeli life sciences venture capital fund, on Monday announced the closing of its first fund, totalling €46 million. Private equity company HarbourVest Partners...

Strong growth for Boehringer

11-Apr-2003 - German pharmaceutical and ingredients group Boehringer Ingelheim, outpacing market growth, ended 2002 with a healthy rise in profits, the company reports this week. Increases in...

Neuro Biosci to buy stake in CLL Pharma

11-Apr-2003 - US Neuro Bioscience has signed an agreement to acquire a minimum of 75 per cent of the issued and outstanding share capital of CLL Pharma,...

PerkinElmer wins analytical award

11-Apr-2003 - US company PerkinElmer was presented with the 2003 Analytical Instrumentation Company of the Year award by market research company Frost & Sullivan in a ceremony...

Steris washes over Europe

09-Apr-2003 - US Steris Corporation has extended operations in Europe with the announcement today that it has acquired Swiss provider of washing/decontamination systems Hamo Holding. The move...

HQ for Euro biotech

09-Apr-2003 - The European Federation of Biotechnology (EFB) is setting up a trade office in Aarhus, Denmark for its activities in innovation and functional genomics, reports Biotech...

Side effect concerns recede for Eprex

07-Apr-2003 - The latest data on cases of antibody-mediated pure red cell aplasia associated with Johnson & Johnson subsidiary Janssen-Cilag's erythropoietin product Eprex/Erypo (epoetin alfa) have suggested...

First shipment for US CDT product to Europe

04-Apr-2003 - US biopharmaceutical company Scolr, latterly known as Nutraceutix, is to ship the first order for its patented controlled delivery product Glucosamine/Chondroitin to Europe. The first-to-market...

Osmetch grows

04-Apr-2003 - UK developer of medical diagnostics devices Osmetech continued the strategy to build on its healthcare diagnostics business with the acquisition this week of the Atlanta-based...

Three killed in DSM plant explosion

04-Apr-2003 - Dutch life science company DSM reported this week that on Tuesday three people were killed following an explosion at its Melamine Plant 2 in Geleen,...

New patent for Chiral Quest

04-Apr-2003 - Life science company Chiral Quest this week announced that the non-profit organisation, the Penn State Research Foundation, has received a US patent covering the compositions...

UK biotech collaboration

04-Apr-2003 - Two British firms, De Novo Pharmaceuticals and Peakdale Molecular, are to enter into a joint collaboration to exploit their respective skills in molecular design and...

New era for Roche

02-Apr-2003 - Shareholders at Swiss pharmaceutical company Roche welcomed the start of a new era as the company summarised recent events, including the divestment of the vitamins...

Gennaissance to break even

02-Apr-2003 - Drug discovery company Genaissance Pharmaceuticals is to acquire bankrupt applied genetics company DNA Sciences for $1.3 million (€1.2 m) in cash. Under terms of the...

Biotechs - facing up to reality

02-Apr-2003 - The bulk of biotech companies are firmly rooted towards the foot of the ladder of corporate evolution. Precious few can realistically claim to be at...

GlaxoSmithKline signs €41 million deal with Flamel

31-Mar-2003 - GlaxoSmithKline has entered into a new drug formulation agreement with Flamel Technologies of France that could see the latter firm receive up to $45 million...

Dow obtains new oligonucleotides contact

31-Mar-2003 - Dow Chemical has agreed for Dowpharma, Dow's pharmaceutical manufacturing services business unit, to supply select, proprietary oligonucleotides to Montreal, Canada-based Topigen Pharmaceuticals for use in...

Biogen digs into Europe

28-Mar-2003 - Biotechnology company Biogen this week celebrated its 25th anniversary by breaking the ground on a large-scale manufacturing facility in Hillerød, Denmark, marking the company's first...

Intercare revenues rise strongly in 2002

26-Mar-2003 - UK contract pharmaceutical manufacturer and distributor Intercare Group has reported 2002 turnover of £275.1 million (€406m), an increase of 27 per cent year-on-year, and pretax...

Pharma boom for Denmark

26-Mar-2003 - Data published by the Danish Association of the Pharmaceutical Industry (LIF) reveals a boom in pharmaceutical exports in 2002. Sales totalled DK30.3 billion (€4.3 billion),...

Bioscience - economic driver for UK ?

26-Mar-2003 - UK Science Minister Lord Sainsbury this week announced a new initiative to develop 'a strategic approach' to the future of the bioscience industry in the...

Forging genomics

24-Mar-2003 - Biotechnology service group SeqWright has entered into an agreement with Fisher Scientific that combines SeqWright's genomic services with Fisher's scientific research products. Under the terms...

Elan and Ingenium embark on pain alliance

24-Mar-2003 - Ireland's Elan Corp has inked a deal with Ingenium Pharmaceuticals of Germany that will see the companies apply Ingenium's functional genomics technologies to the discovery...